Samuel Refetoff to Compassionate Use Trials
This is a "connection" page, showing publications Samuel Refetoff has written about Compassionate Use Trials.
Connection Strength
0.111
-
Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency. J Clin Endocrinol Metab. 2012 Dec; 97(12):4515-23.
Score: 0.111
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.